Sensei Biotherapeutics Files 8-K
Ticker: SNSE · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, disclosure, pharmaceuticals
TL;DR
Sensei Biotherapeutics filed an 8-K on 3/27/25, check it for updates.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on March 27, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Rockville, MD, and operates in the Pharmaceutical Preparations industry. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Sensei Biotherapeutics is making disclosures to the SEC, which could relate to financial performance or other material events impacting the company.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain information that suggests immediate high risk.
Key Numbers
- 001-39980 — SEC File Number (Identifies the company's filing with the SEC)
- 83-1863385 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- March 27, 2025 (date) — Filing Date
- Rockville, MD (location) — Principal Executive Offices
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What specific event triggered this 8-K filing?
The filing indicates a 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as items of disclosure, but the specific triggering event is not detailed in the provided excerpt.
What is the primary business of Sensei Biotherapeutics, Inc.?
Sensei Biotherapeutics, Inc. is classified under Standard Industrial Classification code 2834, which corresponds to 'Pharmaceutical Preparations'.
Where are Sensei Biotherapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
When was this 8-K form filed with the SEC?
The 8-K form was filed as of March 27, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).